Actively Recruiting
CGM-Enhanced DPP to Prevent Type 2 Diabetes in Adults With Prediabetes
Led by State University of New York at Buffalo · Updated on 2026-04-24
214
Participants Needed
1
Research Sites
98 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Prediabetes affects over one-third of adults in the United States, placing them at a higher risk for developing type 2 diabetes and heart disease, which can lead to serious health complications and increased medical costs. Although a program called the Diabetes Prevention Program (DPP) has been shown to lower the risk of diabetes through healthy lifestyle changes, many people find it difficult to stick with these changes over the long term. This study seeks to find out if combining DPP coaching with continuous glucose monitoring (CGM) technology can help people stay on track with their health goals.
CONDITIONS
Official Title
CGM-Enhanced DPP to Prevent Type 2 Diabetes in Adults With Prediabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older
- Diagnosis of prediabetes by clinical guidelines (HbA1c 5.7% to 6.4%, fasting plasma glucose 100-125 mg/dL, or 2-hour plasma glucose 140-199 mg/dL after a 75g oral glucose tolerance test)
- Body mass index (BMI) of at least 24 kg/m², or at least 22 kg/m² for Asian Americans
- Willingness to comply with all study procedures, including attending coaching sessions and using CGM devices
You will not qualify if you...
- Diagnosis of type 1 or type 2 diabetes
- Current use of continuous glucose monitors or medical reasons preventing CGM use, such as severe skin allergies or implantable defibrillators
- Enrollment in another clinical trial for prediabetes
- Significant dementia, alcohol or drug abuse/dependency, active psychosis
- Life expectancy less than 12 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Division of Population Health, Department of Medicine
Buffalo, New York, United States, 14203
Actively Recruiting
Research Team
R
Raphael A Fraser, PhD, MS
CONTACT
J
Jocelyn Stooks, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here